Announced
Completed
KKR made a minority investment in Oyster Point Pharma.
Synopsis
Private equity firm KKR & Co, through its investment platform Falcon Vision, made a minority investment in Oyster Point Pharma, a clinical-stage pharmaceutical company that develops therapies to treat Dry Eye Disease. Financial terms were not disclosed.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.